Most New Drugs Never Make it to Market

The amazing speed with which the pharmaceutical industry developed, tested and won emergency approval for the COVID-19 vaccine was not just surprising, but in at least one way, misleading.

As the new report, Clinical Development Success Rates and Contributing Factors 2011 – 2020 from Bio.org makes clear, the COVID vaccines and therapeutics that became available mere months into the pandemic were a dramatic and rare exception.

On average, the report tells us it takes almost 11 years to go from a Phase I program to regulatory approval. And that’s only for those drugs and therapies that make it through. Over the 10 years from 2011, the likelihood that a drug in a Phase I trial would ultimately win approval was 7.9%.

That may be better odds than winning the Powerball lottery, however, the investment in a drug’s development can dwarf all but the largest jackpots. Making it even more of a gamble for a pharmaceutical firm is that the average success rate has declined since Bio’s 2016 report. Then the average for the previous 10 years was 9.6%.

Heavy with tables, charts and graphs, the Bio.org report (in conjunction with Informa Pharma Intelligence and QLS Advisors) reviews success rates across 21 major diseases. It reports specifics on 14 of them, combining the balance into an “Other” category. The detailed diseases are: Allergy, Autoimmune, Cardiovascular, Endocrine, Gastroenterology (non-IBD), Hematology, Infectious disease, Metabolic, Neurology, Oncology, Ophthalmology, Psychiatry, Respiratory, and Urology.

Comparing the success rates in the current report to the previous one, Bio found 12 categories had a lower likelihood of progressing from Phase 1 to approval. The largest decline was in urology. In the 2016 report, therapeutics in this category averaged 11.4% success. In the recent report, the average fell to 3.6%.

Hematology has the highest likelihood of approval at 23.9%, though it too saw a decline from 26.1%.

Drugs to treat rare diseases fared better than other therapies. The report said these drugs had a 17% likelihood of success.

The decrease, explains a Bio.org discussion of the report, “Can be attributed to two main factors: A greater participation from smaller firms participating in drug candidate development and their willingness to disclose early failures.”

Said David Thomas, BIO VP, industry research, “That all ties into what we see, which is a lower success rate overall from our last paper in 2016.”

Drug development remains difficult with far less than 1 in 10 clinical drug programs ever reaching patients,” says the Bio.org account. “It usually takes 10 to 10.5 years to develop a vaccine, which makes the existing COVID-19 vaccines on the market all the more incredible.”

Success, adds Thomas, takes “many shots on goal.”

Photo by ThisisEngineering RAEng on Unsplash

#WeAreGreenKey: Spotlight on Brad Martin
Architecture + Engineering General Interest

#WeAreGreenKey: Spotlight on Brad Martin

Green Key Unlocked: Mastering your Healthcare Interview
General Interest Healthcare

Green Key Unlocked: Mastering your Healthcare Interview

Is Covid-19 Back or Are We Just Seeing a Surge in Cases?
General Interest Healthcare Pharma

Is Covid-19 Back or Are We Just Seeing a Surge in Cases?

Strategic Networking: A Secret Weapon in Job Searching
Accounting + Finance Architecture + Engineering Financial Services General Interest Healthcare Human Resources Information Technology Legal Support Marketing Technology Pharma Professional Support

Strategic Networking: A Secret Weapon in Job Searching

#WeAreGreenKey: Spotlight on Justin Nadelman
General Interest Green Key News Information Technology Leadership + Management

#WeAreGreenKey: Spotlight on Justin Nadelman

Navigating the Tech Interview Maze: A Guide to Success
General Interest Information Technology

Navigating the Tech Interview Maze: A Guide to Success

Green Key Unlocked: How to Succeed in Payroll Management
Accounting + Finance General Interest Human Resources Leadership + Management

Green Key Unlocked: How to Succeed in Payroll Management

#WeAreGreenKey: Spotlight on Jenny Rehkugler
Accounting + Finance General Interest

#WeAreGreenKey: Spotlight on Jenny Rehkugler

Handling Mistakes & Failure in the Workplace
General Interest Worklife

Handling Mistakes & Failure in the Workplace

How to Support Those Affected by Hawai’i Wildfires 
Green Key News

How to Support Those Affected by Hawai’i Wildfires 

#WeAreGreenKey: Spotlight on Halle Sarfin
Green Key News Professional Support

#WeAreGreenKey: Spotlight on Halle Sarfin

Advantages of Offering Exit Interviews
General Interest Human Resources

Advantages of Offering Exit Interviews

Tracking Metrics: Learning & Development
General Interest Leadership + Management Worklife

Tracking Metrics: Learning & Development

#WeAreGreenKey: Spotlight on Leanna Gallagher
Green Key News Human Resources

#WeAreGreenKey: Spotlight on Leanna Gallagher

How to Beat the Summer Productivity Slump
General Interest Leadership + Management Worklife

How to Beat the Summer Productivity Slump

Questions to Ask When Hiring a Recruiter
General Interest Leadership + Management Worklife

Questions to Ask When Hiring a Recruiter

#WeAreGreenKey: Spotlight on Chianté Vidal
Architecture + Engineering Green Key News

#WeAreGreenKey: Spotlight on Chianté Vidal

Celebrating 10 Years of GKR in Rockville
Green Key News Leadership + Management Professional Support

Celebrating 10 Years of GKR in Rockville

Internal Mobility: Retaining Top Talent
General Interest

Internal Mobility: Retaining Top Talent

Green Key Unlocked: The Future of Telemedicine & Virtual Healthcare
General Interest Healthcare Information Technology

Green Key Unlocked: The Future of Telemedicine & Virtual Healthcare

Latest Blog Posts
View All Posts
#WeAreGreenKey: Spotlight on Brad Martin

#WeAreGreenKey: Spotlight on Brad Martin

What I find the most rewarding is the fulfilment of seeing someone take that next step in their career while...
Read More
Green Key Unlocked: Mastering your Healthcare Interview

Green Key Unlocked: Mastering your Healthcare Interview

Staying in the same vein as preparing for success in a tech interview, let’s take a look at how to...
Read More
Is Covid-19 Back or Are We Just Seeing a Surge in Cases?

Is Covid-19 Back or Are We Just Seeing a Surge in Cases?

With the recent increase in hospitalizations and Covid-19 cases across the U.S. the question of How to protect ourselves and...
Read More